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Facilitated binding of p53 to DNA by high mobility
group B1 (HMGB1) may involve interaction between
the N-terminal region of p53 and the high mobility
group (HMG) boxes, as well as HMG-induced
bending of the DNA. Intramolecular shielding of the
boxes by the HMGB1 acidic tail results in an unstable
complex with p53 until the tail is truncated to half its
length, at which point the A box, proposed to be the
preferred binding site for p53(1–93), is exposed,
leaving the B box to bind and bend DNA. The A box
interactswith residues 38–61 (TAD2) of the p53 trans-
activation domain. Residues 19–26 (TAD1) bind
weakly, but only in the context of p53(1–93) and not
as a free TAD1 peptide. We have solved the structure
of the A-box/p53(1–93) complex by nuclear magnetic
resonance spectroscopy. The incipient amphipathic
helix in TAD2 recognizes the concave DNA-binding
face of the A box and may be acting as a single-
stranded DNA mimic.
INTRODUCTION
High mobility group B1 (HMGB1) and HMGB2 are relatively
abundant, highly mobile, nuclear proteins that bind and bend
linear DNA in a sequence-independent manner and bind prefer-
entially to prebent or distorted DNA (reviewed by Bustin and
Reeves, 1996; Thomas and Travers, 2001; Agresti and Bianchi,
2003; Travers and Thomas, 2004; Stros, 2010). DNA binding
is a property of the two basic, homologous but functionally
nonequivalent high mobility group (HMG) boxes (A and B), which
are connected by a short basic linker. DNA bending toward the
major groove occurs as a result of minor-groove binding and
intercalation into the DNA of bulky amino acid side-chains on
the DNA-binding faces of the two HMG boxes. The long, homo-
geneously acidic, C-terminal tail (30 residues in HMGB1, 20 in
HMGB2), which is connected to the boxes by a basic linker,
lowers the DNA-binding affinity of the boxes (Sheflin et al.,
1993; Stros et al., 1994). The tail is necessary for transcriptional
activation in a transfection assay (Aizawa et al., 1994; Banerjee
and Kundu, 2003; Ueda et al., 2004) and is required for preferen-2014 Structure 20, 2014–2024, December 5, 2012 ª2012 Elsevier Ltdtial binding to prebent (e.g., minicircle) DNA relative to linear DNA
in an in vitro competition assay (Lee and Thomas, 2000), as also
shown for the single HMG-box protein HMG-D (Payet and Tra-
vers, 1997). The acidic tail organizes the basic boxes and linkers
into a dynamic assembly, in which the DNA-binding surfaces of
the boxes are occluded (Knapp et al., 2004; Watson et al., 2007;
Stott et al., 2010).
Through its ability to bend DNA, HMGB1 plays an ‘‘architec-
tural’’ role in many DNA-dependent nuclear processes, such
as transcription, replication, recombination, and repair (reviewed
as above). Gel-shift and transient transfection assays show that
HMGB1 facilitates DNA binding of a number of transcription
factors (Zwilling et al., 1995; Zappavigna et al., 1996; Boonyara-
tanakornkit et al., 1998; Lehming et al., 1998; Brickman et al.,
1999; Decoville et al., 2000; Melvin et al., 2004; Najima
et al., 2005), including the tumor suppressor p53 (Jayaraman
et al., 1998; McKinney and Prives, 2002; Banerjee and Kundu,
2003; Stros et al., 2004). One obvious way in which HMGB1
could do this is by binding and distorting the linear DNA into a
more favorable conformation for the transcription factor to bind
(Thomas and Travers, 2001); indeed, HMGB1 does not facilitate
the high-affinity binding of p53 to prebent (minicircle) DNA
(McKinney and Prives, 2002). There may also be a role for
protein-protein interactions (see below). In the case of the Oct-
1 POU domain (whose DNA binding is facilitated by HMGB1),
the POU domain in the POU/DNA complex binds on the inside
of the DNA, which is bent by 30–37 toward the major groove
(Verrijzer et al., 1991; Klemm et al., 1994). In the case of p53
(Joerger and Fersht, 2008), which binds to diverse DNA targets
as a dimer of dimers, the DNA in the complexes is bent by 25–
52, again toward the major groove, with the protein binding on
the inside of the bend (Nagaich et al., 1997; Kitayner et al.,
2006). In this case and that of Oct-1, binding of HMGB1 in the
minor groove, on the outside of a bend toward the major groove,
could clearly promote a DNA conformation to which the tran-
scription factorsmightmore easily bind, on the insideof thebend.
Although transcription factor binding may be facilitated by
HMGB1, there is a general lack of evidence for the presence
of a stable ternary complex, although such complexes between
p53, hemicatenated DNA (a high-affinity substrate), and HMGB1
have been reported (Stros et al., 2004). In general, it is likely that
HMGB1 acts in a highly transient manner to facilitate transcrip-
tion factor binding to DNA, essentially acting as a chaperone.
Its abundance and dynamic nature within the cell (e.g., Catez
et al., 2004) make it an excellent candidate for such a role.All rights reserved
Figure 1. Summary of Proteins and Domains
(A) HMGB1 domain organization (top) and, below: the minimal A box (residues
1–83), the A0 domain (1–88) containing the basic interbox linker, the minimal B
box (88–164), the B0 domain (84–184) with flanking basic linkers, and the
AB and AB0 didomains, which differ in the inclusion of the basic region that
connects the HMG boxes to the acidic tail.
(B) p53 domain organization (top) and sequentially below: p53DBD, the DNA-
binding domain; p53(1–93), consisting of the N-terminal transactivation
domain (1–63) containing the TAD1 (19–26) and TAD2 (38–61) elements and
the proline-rich region (64–93); p53(1–312), p53 lacking the C-terminal region
[the tetramerization domain (313–326), and the regulatory region (327–393)];
and p53(94–393), lacking the N-terminal region.
Structure
Interaction of HMGB1 and p53HMGB1 and p53 are also capable of physical interaction
(Jayaraman et al., 1998; Stros et al., 2004), and this might be
involved in recruitment of HMGB1 to DNA. The HMGB1-interact-
ing region of p53 has been suggested to be a PXXPXP motif in
the proline-rich region (Dintilhac and Bernue´s, 2002) or the
C-terminal region (Imamura et al., 2001). However, p53 interac-
tion with human mitochondrial transcription factor A (TFAM),
which contains two HMG boxes and a basic (rather than acidic)
C-terminal tail, occurs via the TAD1 and TAD2 elements in the
transactivation domain (Wong et al., 2009a).
We show here that an essential element in the interaction
of p53 with HMGB1 is the N-terminal disordered region (Lee
et al., 2000; Dawson et al., 2003; Wells et al., 2008), comprising
the transactivation domain and the proline-rich region, the major
interacting motif being a region of inducible structure in TAD2
(Lee et al., 2000). We present a high-resolution nuclear magnetic
resonance (NMR) structure of the A box/p53(1–93) complex. We
suggest that the A and B boxes play distinct roles in p53-DNA
binding and protein-protein interactions.
RESULTS
The domain structures of HMGB1 and p53, and of the isolated
domains used here, are shown in Figure 1. The HMGB1 A0
domain (Jung and Lippard, 2003) comprises the minimal A box
(Hardman et al., 1995) with a basic TKKK extension that in-
creases its DNA-binding affinity; similarly, B0 (Teo et al., 1995)
contains basic N- and (longer) C-terminal extensions that in-
crease its affinity relative to the minimal B box (Weir et al., 1993).Structure 20, 2014–20Facilitation of p53-DNA Binding Occurs with Full-Length
HMGB1 and the Isolated A0 and B0 Domains
Full-length HMGB1 and the isolated A0 and B0 HMG domains
were all capable of stimulating the binding of p53 to its
consensus DNA in the presence of competitor DNA (Figures
2A–2C), as shown previously (McKinney and Prives, 2002), and
the C-terminal region of p53 (residues 313–393) is not required
(p53(1-312); Figure 2D). In the absence of HMGB1 (or domains),
very little p53 is bound to DNA (lanes 2). Addition of increasing
amounts of HMG protein results in a significant increase in
binding (lanes 3–6), with nonspecific binding of A0 and B0 at the
higher concentrations (lanes 5, 6, 9, and 10), resulting in smear-
ing (Figures 2B and 2C) and, in the case of HMGB1, formation of
a better defined low-affinity complex (Figure 2A). Neither of the
minimal A and B HMG boxes (Figure 1A) could facilitate p53
binding to the oligonucleotide (data not shown), probably
because of their low affinity for DNA in the absence of the basic
extensions that are present in A0 and B0. Facilitation of p53
binding by HMGB1 and its domains does not shift the position
of the p53-DNA complex, and there is no evidence of stable
ternary complexes. (The doublet nature of the p53-DNA complex
band in Figure 2B is probably due to slight degradation of p53 in
this experiment.)
Cross-Linking Reveals Protein-Protein Interactions
between p53(1–312) and the HMG Boxes of HMGB1
Chemical cross-linking using dimethyl suberimidate (DMS) was
used to investigate whether there were protein-protein interac-
tions between the HMG boxes of HMGB1 and p53(1–312) that
might, in principle, be involved in the facilitation of p53 binding
to DNA. In this assay, in contrast to that involving DNA binding
(see above), the basic extensions to the HMG boxes are not
required.
Treatment of equimolar amounts of p53(1–312) and HMGB1,
the AB didomain or its A and B boxes, with DMS revealed
cross-linked products (Figure 2E, lanes 4) that are not present
in the individual protein controls (lanes 2). The complexes with
the A and B boxes have apparent molecular masses consistent
with p53(1–312)/HMG box heterodimers. With the AB didomain,
in addition to a major band consistent with a p53(1–312)/AB het-
erodimer, there is a minor band at a higher molecular mass,
which may be due to a small amount of a 2:1 p53(1–312):AB
complex (see below). The yield of cross-linked product was
much lower for HMGB1 than for the AB didomain or the indi-
vidual HMG boxes, presumably because the acidic tail effec-
tively masks the surfaces of the boxes, preventing binding to
p53(1–312) (Watson et al., 2007; Stott et al., 2010). No novel
cross-linked products were obtained with p53DBD or p53(94–
393) (data not shown), indicating that the p53 N-terminal region
(1–93) is needed for the interaction with the HMG protein
detected by cross-linking. The isolated p53(1–93) fragment and
the A box interact (Figure 2F), and an estimate of the affinity
(Kd 346 nM) was obtained by isothermal titration calorimetry
(ITC) (Figure S1 available online).
Effect of Acidic Tail Truncation on the Interaction of
HMGB1 with p53(1–93)
To test whether the low yield of complex formation (suggested
by cross-linking) between p53 and full-length HMGB1, which is24, December 5, 2012 ª2012 Elsevier Ltd All rights reserved 2015
Figure 2. HMGB1 and the Individual A0 and
B0 Domains Facilitate the Binding of p53 to
Its Cognate DNA via Protein-Protein Inter-
actions between the HMG Boxes and the
p53 N Terminus
(A–C) Gel-retardation assay showing the effects
of increasing concentrations of (A) full-length
HMGB1, (B) A0, and (C) B0 on the binding of full-
length p53 to 32 bpDNA. Autoradiogram is shown.
In each case, lane 1, DNA only; lane 2, DNA + p53;
lanes 3–6, DNA + p53 + increasing amounts of
HMG protein as shown; and lanes 7–10, in-
creasing amounts of HMG protein, as in lanes 3–6,
but no p53.
(D) Same as (A), except with His6p53(1–312).
(E) DMS cross-linking of full-length HMGB1, the
AB didomain, and the A and B HMG boxes with
His6p53(1–312) for the times shown, analyzed in
SDS/18%-polyacrylamide gels.
(F) Same as (E), but with p53(1–93).
See also Figure S1.
Structure
Interaction of HMGB1 and p53deduced to involve the N-terminal region (1–93) of p53, was
indeed due to shielding of the HMG boxes by the acidic tail,
we asked whether tail-truncated derivatives of HMGB1 (Watson
et al., 2007) would form a more stable complex with isolated
p53(1–93). Gel filtration gave no indication of complex forma-
tion with full-length HMGB1 (Figure 3A), but when 15 residues
of the HMGB1 acidic tail (known to be involved in intramolecu-
lar interactions with the A box; Watson et al., 2007; Stott et al.,
2010) were removed, there was clear evidence of a complex2016 Structure 20, 2014–2024, December 5, 2012 ª2012 Elsevier Ltd All rights reserved(i.e., for HMGB1D15; Figure 3C), indi-
cating that HMGB1D15 interacts with
p53(1–93) through its A box. The per-
sistence of some unbound protein
(Figure 3C) suggests that this complex
is partly dissociated, in contrast to
that formed when 25 tail residues
are removed (Figure 3D), exposing the
B box as well. Interestingly, the ab-
sence of free HMGB1D25 in the latter
case suggests that 2:1 complexes of
p53(1–93):HMGB1D25 are not signifi-
cant products; otherwise, at equimolar
protein concentrations, an appreciable
amount of free HMGB1D25 would
remain. Since cross-linking shows that
both boxes can bind p53(1–312) (Fig-
ure 2E), stabilization of the complex
detected by gel-filtration (Figure 3D) is
probably due to an increased concen-
tration of possible binding sites in
HMGB1D25 relative to HMGB1D15,
which would enhance binding without
necessarily resulting in a significant pop-
ulation of 2:1 complexes. (A low con-
centration of such complexes might
be formed [see upper cross-linked band
for AB in Figure 2E], but since no ter-nary complexes were detected by gel filtration, this must be
unfavorable.)
NMR Chemical-Shift Mapping
The results of chemical cross-linking indicate that both of the
isolated A and B boxes, which show sequence and structural
homology, can interact with p53(1–93). Chemical-shift map-
ping was used to identify the interacting surfaces. The results
obtained from titrating unlabeled p53(1–93) into 15N-labeled
Figure 3. Gel-Filtration Analysis of the
Interaction of p53(1–93) with Full-Length
HMGB1 and the Tail-Truncated Derivatives
HMGB1D10, HMGB1D15, and HMGB1D25
Elution profiles for (A) HMGB1, (B) HMGB1D10, (C)
HMGB1D15, and (D) HMGB1D25 alone (in black)
andwhenmixed with p53(1–93) at a 1:1 molar ratio
(blue). The profile for p53(1–93) alone is shown in
magenta.
Structure
Interaction of HMGB1 and p53full-length HMGB1, its A or B box, or D30 didomain are shown in
Figure 4A. In the case of full-length HMGB1, the peaks do not
shift significantly, indicating that any interaction with p53(1–93)
is very weak; it appears that p53(1–93) is unable to compete
effectively with the intramolecular interaction between the acidic
tail and residues in helices I and II of the A and B boxes and the
basic linkers (Watson et al., 2007; Stott et al., 2010). In contrast,
and consistent with the results of gel filtration and chemical
cross-linking, the spectra of the A and B boxes and of D30
show many shifted peaks. The shifts are large and progressive,
with some peaks becoming broader and less intense, indicative
of an interaction that is of moderate strength and occurring at
a rate that is fast-to-intermediate on the NMR chemical-shift
timescale [consistent with the Kd of 346 nM obtained for
A/p53(1–93) by ITC (Figure S1)]. The shift trajectories are remark-
ably similar, indicating that the chemical environment of the
p53 residues is similar in the complexes, regardless of whether
the A or B box is involved. The 1H and 15N shift changes
were combined and quantified (Figure 4B). For both the A and
B boxes, the shift changes are similar in magnitude and distribu-
tion, the interacting residues being predominantly located in
helices I and II (with additional moderate shifts at the extreme
N- and C-terminal ends of the B box, which may be due
to stabilization of ‘‘frayed ends’’ of the minimal B box, as seen
previously; Stott et al., 2006; Watson et al., 2007). For D30, the
shift changes are generally smaller than for the individual A and
B boxes, presumably due to the availability of two boxes; the
binding of p53(1–93) is therefore effectively partitioned between
them. [There was no evidence of a ternary complex in gel-filtra-Structure 20, 2014–2024, December 5, 2012 ªtion experiments (Figure 3D), although
a small amount was seen by cross-linking
Figure 2E.] As in the case of the individual
boxes, the largest shifts in D30 occur for
residues in helices I and II, indicating
that the mode of interaction with the A
and B boxes is similar for the isolated
boxes and in the context of the didomain.
However, for D30, there are additional
large shifts at the C-terminal end of the
A box, close to the inter-domain basic
linker, 84TKKK87, which could be due
to additional interactions or a conforma-
tional change in this flexible region.
The titrations were then performed
in reverse using 15N-labeled p53(1–93),
with addition of the A or B boxes, the
D30 didomain, or full-length HMGB1
(Figures 5A–5D). Large, progressive shiftchanges and associated peak broadening were seen for many
residues in all cases, except the titration with full-length
HMGB1, in which the shift changes were relatively insignificant.
The shift changes were quantified as above. Residues with reso-
nances undergoing significant chemical-shift changes were
located in the region spanning residues 18–57, which contains
the elements of nascent secondary structure, namely TAD1 (resi-
dues 14–28) and TAD2 (residues 38–61) (Lee et al., 2000), with
the largest changes occurring in TAD2. No significant shifts
were observed for residues 59–93 (see, for example, Figure 5A),
showing that the proline-rich region containing the PXXPXP
motifs, previously suggested to be the site of interaction (Dintil-
hac and Bernue´s, 2002), is not involved.
The A and B boxes induce shift changes in p53(1–93) that
are of similar magnitude (B slightly greater than A) and pattern
(Figures 5A and 5B), indicating that the interaction of each
box is similar in both strength and mode. For D30, which con-
tains twice the concentration of possible interacting sites, the
chemical-shift changes for TAD2 are slightly larger than with
the individual HMG boxes (Figure 5C). In addition, the shift
changes for TAD1, although still small, are significantly larger
than for the individual boxes, suggesting the presence of addi-
tional interactions, perhaps due to the presence of an additional
box (or two basic linkers). In contrast, the shift changes induced
by full-length HMGB1 are more than an order of magnitude
smaller than those resulting from interaction with the isolated A
or B boxes, but the largest shifts are again located in TAD2.
In order to establish whether TAD1 (which showed relatively
weak chemical-shift changes) and TAD2were capable of binding2012 Elsevier Ltd All rights reserved 2017
Figure 4. NMR Chemical-Shift Mapping of
the Binding of 15N-HMGB1 and Its Domains
to p53(1–93)
(A) Titrations of unlabeled p53(1–93) into 15N-
labeled A box, B box, D30 didomain, and full-
length HMGB1 monitored by two-dimensional
(2D) 15N-HSQC experiments. p53(1–93) was
added at a p53(1–93):HMGB1 ratio of 0.5:1 (blue),
1.0:1 (green), and 1.5:1 (red); in black, HMGB1
alone
(B) Chemical-shift changes quantified using Dd =
[(Dd H)2 + (0.15 3 Dd N)2]1/2 (Zuiderweg, 2002).
See also Figure S1.
Structure
Interaction of HMGB1 and p53independently to the HMG boxes, the chemical-shift mapping
was repeated using 15N-labeled A box and two peptides, p53
(14–28) and p53(38–61), corresponding to TAD1 and TAD2,
respectively. TAD2 induced chemical-shift changes of similar
magnitude to those caused by p53(1–93), while no shifts were
observed for TAD1 (Figures 6A and 6B). TAD2 therefore appears
to be the key interacting element within the intact p53 transacti-
vation domain. This was supported by ITC, in which TAD1 gave
no detectable heat of binding, while TAD2 bound the A and B
boxes with similar but slightly lower affinity than p53(1–93) (Kd
631 nM for TAD2/A compared with 346 nM for p53(1–93)/A; Fig-
ure S1), consistent with a weak involvement of TAD1 in the
context of the longer construct.
StructureDetermination of theComplex of theHMGB1A
Box with p53(1–93)
Complexes of 13C,15N-A/p53(1–93) and A/13C,15N-p53(1–93) for
structural analysis were prepared by titration. All backbone 1Ha,
15N, 13Ca, and 13C0 resonances were assigned in the complexes,2018 Structure 20, 2014–2024, December 5, 2012 ª2012 Elsevier Ltd All rights reservedwith the exception of Pro12 and Pro71
1Ha in p53, Gly1 in A, and all 13C0
preceding proline. All non-exchangeable
side-chain 1H, 13C, and 15N resonances
were assigned, with the exception of
Pro12, Pro71 and Cε/(Hε)3 of Met1 in
p53 and Gly1 and Lys2 Cε/Hε2,3 in the
A box. All Gln Nε2/Hε21,22 and Asn Nd2/
Hd21,22 resonances were assigned. Com-
parison of 13Ca and 13Cb shifts with those
for a random coil (Schwarzinger et al.,
2001) showed that complex formation
stabilizes 2.5 turns of helix in TAD2 (Fig-
ure 6C; red bars). Automated structure-
based assignment was performed in
ARIA (Linge et al., 2003) using a com-
bination of nuclear Overhauser effect
(NOE), torsion angle, and hydrogen
bond restraints as input for the Crystal-
lography and NMR System (CNS)
(Bru¨nger et al., 1998). Fifty-seven unam-
biguous and 3,069 ambiguous NOE
restraints were used for the first iteration,
of which eight unambiguous and 64
ambiguous were from a three-dimen-
sional (3D) [F1]-13C/15N-filtered NOEspectroscopy (NOESY)-13C-heteronuclear single quantum
coherence (HSQC) experiment (Zwahlen et al., 1997). No inter-
molecular NOEs were observed outside TAD2. One hundred
structures were calculated, from which the ten lowest-energy
structures were well converged (root-mean-square deviation
[rmsd] 0.837 A˚ over the structured regions; see Table 1), with
no violations greater than 0.5 A˚. The ensemble of structures is
shown in Figure 6D and diagrams depicting the lowest-energy
structure in Figure 6E.
The bound region of p53(1–93), the TAD2 element, is folded
into a single helical turn (residues 41–44) that is connected by
a sharp turn (residues 45 and 46) to a longer helix (residues
47–55). The hydrophobic residues that are arrayed on one side
of the turn (Leu43, Met44, and Leu45) and longer helix (Ile50,
Trp53, and Phe54) bind deep in the concave DNA-binding face
of the A box, while the acidic residues (Asp48, Asp49, Glu51,
Glu56, and Asp57) point outward (Figure 6E, right panel). The A
box undergoes no such dramatic structural change upon com-
plex formation. However, helix I is shifted to a position such
Figure 5. NMR Chemical-Shift Mapping of
the Binding of 15N-p53(1-93) to HMGB1 and
Its Domains
Titrations of 15N-labeled p53(1–93) with unlabeled
(A) A box, (B) B box, (C) D30 didomain, and (D)
full-length HMGB1 monitored by 2D 15N-HSQC
experiments; quantification as in Figure 4. HMGB1
or its domains were added at an HMGB1:p53
(1–93) ratio of 0.5:1 (blue), 1.0:1 (green), and 1.5:1
(red); in black, HMGB1 alone.
See also Figure S1.
Structure
Interaction of HMGB1 and p53that it lies almost parallel to helix II, thereby forming a more
extensive interface with TAD2. In addition, the linker between
helices I and II is more extended, reminiscent of the A box
complex with cis-platinated DNA (Ohndorf et al., 1999). The
DNA-intercalating residue in the A box, F37 (Ohndorf et al.,
1999), makes extensive hydrophobic contacts with the long helix
of TAD2; p53 and DNA binding by the A box would therefore be
mutually exclusive.Structure 20, 2014–2024, December 5, 2012DISCUSSION
HMGB1 may play a dual chaperone role
in the facilitation of the binding of p53 to
DNA. This partition of function is rational-
ized in terms of the different properties
of the two HMG boxes—the A box
interacting with the transcription factor,
possibly recruiting it or stabilizing its inter-
action with DNA, and the B box bending
the DNA toward the transcription factor,
lowering the energy for binding. Here we
show that the HMG boxes of HMGB1
are capable of facilitating p53-DNA bind-
ing via protein-protein interactions and
that a region of inducible structure in the
p53 transactivation domain (TAD2; resi-
dues 38–61) is the essential element in
these interactions.
The NMR structure of the A box/p53
(1–93) complex (Figure 6E) reveals that
complex formation is driven by interac-
tions between the inducible amphipathic
helix in TAD2 and the concave DNA-
binding face of the HMG box. The
interactions are primarily hydrophobic,
occurring between the TAD2 helix and
minor-groove-binding residues in the
HMG box. Electrostatic interactions
occur between acidic residues on the
outer face of TAD2 and basic DNA-
binding residues in the HMG box. The
a1 and a2 helices of the HMG boxes
of TFAM bind similarly to p53 TAD2
and TAD1 (Wong et al., 2009a). The
induced structure in TAD2 resembles the
structure adopted in TAD2(33–60) bound
to replication protein A (Bochkarevaet al., 2005), in which the aromatic and isoleucine side chains
in the helix are clustered and mediate the interaction with the
single-stranded DNA binding cleft, while the acidic side chains
are exposed to solvent. As pointed out in these and other studies
(Rajagopalan et al., 2009; Wong et al., 2009b), TAD2 exhibits
structural features reminiscent of single-stranded DNA, to which
HMGboxes are known to bindwith higher affinity than to double-
stranded DNA (Isackson et al., 1979).ª2012 Elsevier Ltd All rights reserved 2019
Figure 6. Confirmation of TAD2 as the
Primary Binding Site and Structure of the A
Box/p53(1–93) Complex
(A) Titration of 15N-labeled HMGB1 A box with
unlabeled TAD1 and TAD2 peptides (residues 14–
28 and 38–61, respectively). Only TAD2 shows
chemical-shift changes indicative of binding
(ratios of TAD1/2:A box are 0.5:1 [blue] and 1.0:1
[red]; black, TAD1/2 alone).
(B) TAD2 binds to the A box in the same mode
and with the same affinity as the parent domain,
p53(1–93) (Figure 5), as demonstrated by the
closely overlapping chemical-shift profiles.
(C) Helical structure is induced in TAD2 in the A
box/p53(1–93) complex. D(DCa–DCb) is the devi-
ation from residue-dependent random-coil shift
values (Schwarzinger et al., 2001) of Ca and Cb.
Consecutive positive or negative shift values
indicate regions of a-helix or b sheet, respectively
(Metzler et al., 1993). An a-helix of 2.5 turns is
stabilized in TAD2 on binding to the A box, shown
by the red bars. Deviations from random coil
intrinsic to the free protein and the complex are
shown as empty and gray bars, respectively.
(D) Ensemble of the ten lowest-energy NMR
structures of the A/p53(1–93) complex generated
byMOLMOL (Koradi et al., 1996) (A box in red, p53
[1–93] in blue; only the structured residues of the
complex are shown). The rmsd is 0.837 A˚ over the
backbone residues.
(E) Two views of the complex generated by
MOLSCRIPT (Kraulis, 1991) and Raster3D (Mer-
ritt and Bacon, 1997); HMGB1 A box in
pink and p53 in blue ribbons. Backbone N atoms
of interacting residues on the A box are shown
in red space-fill. Right: alternative view showing
that the amphipathic helix of p53TAD2 docks
on to the concave DNA-binding face of the A
box. Hydrophobic residues (Leu43, Leu45, Ile50,
Trp53, and Phe54) are buried, while charged
residues (Asp48, Asp49, Glu51, and Glu56) re-
main solvent-exposed (side-chains shown as
sticks). Phe37 of the A box, which intercalates
between DNA base pairs in the A box complex
with cisplatin-modified DNA (Ohndorf et al.,
1999), is shown in red.
See also Figure S1.
Structure
Interaction of HMGB1 and p53Ser46 and Thr55 in TAD2 can be phosphorylated in vivo (Li
et al., 2004; Oda et al., 2000). The A box/p53(1–93) structure
shows that Ser46 is close enough to form a salt bridge between
the phosphate group and Lys42 and/or Lys49 on helix II of the A
box, and similarly, Thr55 is close to Arg23 and/or Lys27 on helix I
of the A box—interactions that would be expected to increase
the stability of the complex several-fold, as seen for other part-
ners (Di Lello et al., 2006; Rajagopalan et al., 2009; van Dieck
et al., 2009).
The isolated B box is expected to form a similar complex
with p53(1–93); the chemical-shift changes in the complex occur
in the same regions and are of similar magnitude (Figures 4
and 5) as for the A box, and the Kd is almost identical (Fig-
ure S1B). Interestingly, for D30 (HMGB1 lacking the acidic tail),
there was evidence to suggest both competition between the
A and B boxes for p53TAD2 (Figure 4B) and increased involve-
ment of TAD1 (Figure 5C), but it was not possible to determine2020 Structure 20, 2014–2024, December 5, 2012 ª2012 Elsevier Ltdthe partitioning of the binding of TAD1 and TAD2 between the
A and B boxes and basic linkers.
In a complex between p53 and HMGB1 mediated by TAD2
and the A box, TAD1 would be free to bind other proteins.
Such a situation indeed arises in the ternary complex of p53
with the human homolog of murine double minute 2 (HDM2)
and CREB binding protein (CBP), which bind via TAD1 and
TAD2, respectively (Ferreon et al., 2009). TAD1 may also play
a more significant role in interaction with HMGB1 when phos-
phorylated (Xu, 2003).
The acidic tail, which occludes the DNA- and p53-binding face
of the HMG boxes (Watson et al., 2007; Stott et al., 2010), plays
an important role in the regulation of HMG-box/p53 as well as
HMG-box/DNA interactions. It can be competed off by DNA
(Thomas and Stott, 2012) or released by other factors that
are known to bind to the tail in a chromatin environment, e.g.,
histones H1 (Cato et al., 2008) and H3 (Ueda et al., 2004), orAll rights reserved
Table 1. Restraints Used in the Final Iteration of the Calculation
of theA/p53(1–93) Complex Structure andCharacterization of the
Ensemble of Energy-Minimized Structures
NOE Constraints
Total 2,622
Intraresidue 1,156
Sequential (ji  jj = 1) 692
Medium range (ji  jj < 5) 350
Long range (ji  jj > 4) 424
Exclusively intermolecular 71
Dihedral Angle Constraints
Total 226
Hydrogen Bond Constraints
Total 82
Residual NOE Violations (A˚)
NumberR 0.5 0.0 ± 0.0
NumberR 0.1 26.4 ± 4.7
Maximum 0.39
Residual Angle Violations ()
NumberR 2.0 0
Energies (kcal mol1)
Total 5,066 ± 246
van der Waals 1,077 ± 67
Electrostatic 5,191 ± 186
Ramachandran Statistics (% residues)
Core regions 84.9
Allowed regions 13.4
Generously allowed regions 1.5
Disallowed regions 0.2
Rmsd from Ideal Geometry
Bond lengths (A˚) 0.0035 ± 0.0001
Bond angles () 0.512 ± 0.003
Rmsd to Mean Coordinates (A˚) Backbone Heavy atoms
A (7–74) 0.728 1.203
p53 (43–55) 0.600 1.051
A (7–74) + p53 (43–55) 0.862 1.277
Ten water-refined, energy-minimized structural conformations were
analyzed. Ramachandran statistics calculated using PROCHECK (Las-
kowski et al., 1993).
Figure 7. Chaperone Roles for HMGB1 in Facilitation of p53 Binding
to DNA
In both cases, the acidic tail of HMGB1, which occludes the boxes and
linkers in a dynamically assembled intramolecular complex and regulates
binding of DNA and other factors, must be fully or partially displaced
(see text). Various chaperone roles have been proposed (Thomas and Tra-
vers, 2001; McKinney and Prives, 2002; Agresti and Bianchi, 2003; Stros,
2010).
(i) Protein chaperone role. The A box, which is transiently exposed, recruits
p53 (or is recruited by p53) via direct interaction with TAD2. The B box
then binds and bends the DNA, providing a favorable conformation for p53
binding.
(ii) DNA chaperone role. The B box, with its higher DNA-binding affinity bends
DNA, leaving the A box (which binds less strongly to linear DNA) to recruit p53,
which then binds readily to the pre-bent DNA. (A and B boxes [1AAB, Hardman
et al., 1995 and 1HME, Weir et al., 1993] in red and blue, respectively; basic
linkers in yellow, acidic tail in green, and DNA in solid gray.) p53 is drawn in its
tetrameric state (the DNA-bound form), with one TAD as ribbons to show the
regions of inducible helix, where relevant. Recruitment of additional HMGB1
molecules by one or more of the three remaining TAD2 could enhance DNA-
binding further (data not shown). Ribbon structures were generated using
MOLSCRIPT and Raster3D.
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Interaction of HMGB1 and p53possibly another region of p53 (a cytoplasmic complex of intact
p53 and full-length HMGB1 has recently been reported; Livesey
et al., 2012).
Although structurally similar to the B box, the A box has
a higher preference for distorted DNA, whereas the B box is
more effective at bending linear DNA (Paull et al., 1993; Teo
et al., 1995; Webb and Thomas, 1999). The A box is less tightly
sequestered by the acidic tail than the B box at ‘‘physiological
ionic strength’’ (Stott et al., 2010) and appears to be critical for
stimulation of p53-mediated transcription in an in vivo study
(Banerjee and Kundu, 2003). It is therefore likely that the A box,
with its greater availability, is the recruiter of p53 via TAD2 and
that the B box, via its ability to bend DNA, provides a favorable
DNA structure to which p53 can bind. We therefore proposeStructure 20, 2014–20that the A box acts as a protein chaperone and the B box as
a DNA chaperone in a concerted mechanism for the facilitation
of binding of p53 to its cognate DNA, modulated by the acidic
tail (Figure 7). The precise sequence of events is unclear; the
initial protein-protein encounter might occur on, off, or simply
in the vicinity of the p53 binding site. What is clear is that the
interactions involving HMGB1 are likely to be short-lived, their
strength subtly modulated by mass-balance effects and post-
translational modifications.24, December 5, 2012 ª2012 Elsevier Ltd All rights reserved 2021
Structure
Interaction of HMGB1 and p53EXPERIMENTAL PROCEDURES
Expression and Purification of Proteins
Expression and purification of HMGB1 and the tail-truncation products (Wat-
son et al., 2007; Cato et al., 2008), the individual A (Hardman et al., 1995) and B
(Weir et al., 1993) boxes and AB (Grasser et al., 1998) and B0 (Teo et al., 1995)
domains (unlabeled and 15N-labeled), were carried out as described. The A0
domain cloned into plasmid pET32Xa/LIC (provided by S. Lippard) was ex-
pressed and purified as described (Jung and Lippard, 2003). The expression
and purification of p53, p53(1–93), p53(1–312), p53(94–393), and p53(94–
312) (DBD) are described in Supplemental Experimental Procedures. Protein
concentrations were determined by automated amino acid analysis (by Peter
Sharratt, Department of Biochemistry Protein and Nucleic Acid Chemistry
Facility).
p53 Peptides
p53(14–28) was synthesized by M. Weldon in the Department of Biochemistry
Protein and Nucleic Acid Chemistry Facility. p53(38–61) was obtained fromGL
Biochem (Shanghai) Ltd. Both peptides were N-terminally acetylated and
C-terminally amidated and dialyzed without further purification into NMR
buffer (see below). Peptide concentrations were determined by amino acid
analysis (see above).
Gel-Retardation Assays
The assays used a 32P-50-end labeled 32 bp oligonucleotide (Jayaraman et al.,
1998, McKinney and Prives, 2002) containing the p53 consensus DNA binding
site from the human GADD45 promoter (el-Deiry et al., 1992). Binding reac-
tions (20 ml) containing 25 nM p53 or its domains and increasing amounts of
HMGB1 or its domains in 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid, pH 7.9, 50 mM NaCl, 1 mM dithiothreitol (DTT), 1 mM MgCl2,
1 mM EDTA, 20 mg/ml BSA, and 2 mM spermidine were incubated at 23C
for 10min; labeled 32-mer DNA (2.5 nM final concentration) and 75 ng sheared
salmon sperm competitor DNA were then added. After 10 min at 23C, the
mixtures were subjected to electrophoresis at 4C for 3 hr at 160 V in 6%
polyacrylamide/0.5 3 Tris-borate-EDTA gels (pre-electrophoresed under the
same conditions). Vacuum-dried gels were exposed (16 hr, 23C) to
storage phosphor screens, which were scanned (STORM 840 scanner) and
analyzed using ImageQuant software (Molecular Dynamics).
Protein Cross-Linking
Equimolar mixtures of HMGB1 or its domains and His6p53(1–312), or p53
(1–93), at a total protein concentration of 1 mg/ml in 10 mM sodium phos-
phate, pH 7.2, were treated at 23C with 0.2 mg/ml DMS (from a fresh
10 mg/ml stock of the dihydrochloride (Sigma) in 100 mM triethanolamine).
Ten-microliter samples were removed at various times into 0.5 vol of 3X
SDS-gel loading buffer, and the samples were immediately heated in a boiling
water bath for 1 min before electrophoresis in 6 cm SDS/18%-polyacrylamide
gels (Thomas and Kornberg, 1975).
Analytical Gel-Filtration
0.3 mM solutions of p53(1–93) and HMGB1 or its C-truncated products were
prepared in 10 mM sodium phosphate pH 7.2, 50 mM NaCl, 1 mM EDTA,
1 mM DTT and mixed at a 1:1 molar ratio. Ten microliters of the mixture (or
of the individual proteins) was loaded onto a Superdex-75 3.2/30 analytical
gel-filtration column mounted on a SMART FPLC system (GE Healthcare)
and eluted at 40 ml/min. Protein elution wasmonitored at 280 nm, and fractions
were analyzed in SDS/18%-polyacrylamide gels as above.
NMR Spectroscopy
NMR measurements were made on 15N- or 13C,15N-labeled proteins (0.1–
1.0 mM) in 10% 2H2O, 10 mM sodium phosphate pH 7.0, 1 mM EDTA,
1 mM DTT, 0.5 mM phenylmethanesulfonylfluoride on Bruker DRX500 or
DRX800 spectrometers, at 25C unless otherwise stated. Data were pro-
cessed using the AZARA suite of programs (v. 2.8, 1993–2012; Wayne
Boucher and Department of Biochemistry, University of Cambridge, unpub-
lished data). Assignments were made using CcpNmr Analysis v. 2.1 (Vranken
et al., 2005). For HMGB1, D30, and the A and B boxes, backbone assignments
were derived by comparison with previously assigned spectra (Weir et al.,2022 Structure 20, 2014–2024, December 5, 2012 ª2012 Elsevier Ltd1993; Hardman et al., 1995; Watson et al., 2007; Stott et al., 2010), and any
ambiguities were resolved using 3D NOESY-15N-HSQC and total correlation
spectroscopy-15N-HSQC experiments (Cavanagh et al., 1996). For p53(1–
93), published assignments (Lee et al., 2000; Vise et al., 2005; Teufel et al.,
2007) were used as a guide, but a complete assignment of the protein back-
bone and side-chain resonances was obtained essentially ab initio using es-
tablished methods (Cavanagh et al., 1996). The temperature was reduced to
5C for the assignment, since the peak line-shapes were optimal at this
temperature, and the assigned peaks were subsequently tracked to their
25C positions by increasing the sample temperature in a step-wise fashion.
Complexes of 13C,15N-A/p53(1-93), and A/13C,15N-p53(1–93) for structural
analysis were prepared by titrating unlabeled protein into 13C,15N-labeled
protein until no further change in chemical shifts was observed in a 15N-
HSQC spectrum of the labeled component (1.5:1 molar ratio unlabeled:
labeled). Interproton distance restraints were derived from the NOE peak
heights in three NOESY-type spectra (3DNOESY-13C-HSQC, 3DNOESY-15N-
HSQC, 3D [F1]-13C/15N-filtered NOESY; Zwahlen et al., 1997) recorded on
each complex. Backbonef and c torsion-angle restraints were obtained using
DANGLE (Cheung et al., 2010) and restrained toR±20. Backbone hydrogen-
bonding restraints (rNH-O = 1.5–2.5 A˚; rN-O = 2.4–3.5 A˚) were included where
there was unequivocal evidence of a-helical conformation, e.g., from a con-
sensus between DANGLE and medium-range NOEs. The restraints provided
the input for the iterative assignment protocol ARIA v.1.2 (Linge et al., 2003),
in which peak heights were converted into distances using the relaxation
matrix method (including spin diffusion), and r6 summation was used for
the ambiguous NOEs. Torsion-angle molecular dynamics simulations were
performed using CNS (Bru¨nger et al., 1998). The ambiguous cut-off parameter
p was reduced from 0.9999 to 0.8 over iterations 0–8; 20 structures per itera-
tion were calculated for iterations 0–7 and for iteration 8, 100 structures were
calculated with the violation tolerance set to 0.1 A˚. The ten lowest-energy
structures were subjected to a water refinement to give the final ensemble.
ACCESSION NUMBERS
The A box/p53(1-93) complex assignments have been deposited in the Biolog-
ical Magnetic Resonance Data Bank under accession number 18709 and the
coordinates in the Protein Data Bank under accession number 2LY4.
SUPPLEMENTAL INFORMATION
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and one figure and can be found with this article online at http://dx.doi.org/
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